Scapho 150mg DESCRIPTION : Scapho 150mg dose belongs to monoclonal antibody which is a protein which recognises and connect to an inflammatory protein called Interleukin 17A (IL-17A). In patients with psoriatic arthritis and ankylosing spondylitis, the body’s immune system produces an increased amount of IL-17A which causes the symptoms such as swollen and painful joints,Scapho is a prescription drugs which is used under proper guidance of medical oncologist.
INDICATION : Scapho indicated for the treatment of following condition Plaque Psoriasis Psoriatic arthritis Ankylosing spondylitis.
MECHANISM : Scapho 150mg consist of human IgG1 monoclonal antibody which selectively binds to IL-17A, rapidly prohibiting its pro-inflammatory effects. scapho 150mg dose mechanism as Interleukin-17A (IL-17A) is a cornerstone cytokine (messenger protein) contains in the development of psoriasis and is found in peak concentrations in psoriasis plaques.
PRECAUTION : Before to initiation of scapho,start with anti-TB therapy in patients with a history of latent or active TB in whom an adequate course of treatment cannot be confirmed May infuriate Crohn disease Anaphylaxis and cases of urticaria resulted; if this appears, discontinue scapho immediately and start anaphylaxis treatment.